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Abstract: Malignant melanoma is a highly aggressive form of skin cancer which has a propensity for
metastasis. Epithelial mesenchymal transition (EMT) plays a primordial role in the progression of
metastatic disease. Metastatic melanoma is resistant to conventional therapies. Hence, researchers
have been exploring alternative approaches, including the utility of bioactive phytochemicals to
manage metastatic disease. In the present study, we investigated the potential of cirsiliol, a flavonoid
isolated from Centaurea jacea L., in modulating the aggressive behavior of B16F10 metastatic melanoma
cells, including EMT, and associated molecular mechanisms of action. Cirsiliol was found to be
effective in restraining the colony formation and migration of fibronectin-induced B16F10 metastatic
melanoma cells. Cirsiliol inhibited the activity and expression of matrix metalloproteinase-9 (MMP-9).
Cirsiliol also suppressed the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (also known as
Akt)/nuclear factor-κB (NF-κB) signaling pathway which, in turn, caused upregulation of E-cadherin
and downregulation of N-cadherin, Snail and Twist. Based on these results, cirsiliol may be considered
a promising compound against EMT in the therapeutic management of malignant melanoma.
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1. Introduction
Malignant melanoma is the most aggressive form of skin cancer. About 91,270 new incidences of
melanoma (55,150 in men and 36,120 in women) and 9320 deaths (5990 men and 3330 women) due to
this disease are estimated to occur in the United States in 2018 [1]. The rates of melanoma have been
rising for the last 30 years. It is represented by an overall mortality rate of around 20% and is responsible
for 80% of global skin cancer-related deaths [2]. Early-stage melanoma can be effectively treated with
surgery, but metastatic melanoma is highly resistant to conventional therapies [3]. The high rate of
mortality is related to its chemotherapy resistance, aggressive behavior, and propensity to metastasize
rapidly [4].
Melanoma is not of epithelial origin, rather it develops from neural crest-derived pigmented
melanocytes. However, the hallmarks of epithelial-to-mesenchymal transition (EMT) play critical
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roles in its progression [5]. EMT is a dynamic and reversible process where polarized epithelial
cells transform into motile mesenchymal cells and is propagated to be a critical event for tumor cell
invasiveness [6,7]. Differentiated melanocytes express epithelial (E)cadherin, which is required for
their association with keratinocytes in the basal epidermal layer. Loss of Ecadherin represents a
hallmark of EMT in epithelial tumors which is also evident during nodal metastases in malignant
melanoma [8]. EMT-inducing transcription factors, including Snail, Twist, and zinc finger Ebox (ZEB),
play important roles in malignant melanoma, but their regulation and function are different from those
in epithelial cancers [8,9]. The phosphatidylinositol-3-kinase (PI3K) pathway is known to be crucially
involved in melanoma [2], and this pathway plays a significant role in EMT [10]. Ras transcription
is associated with positive regulation of the PI3K/protein kinase B (Akt) signaling pathway, which
leads to activation of Akt and its downstream targets. Activation of PI3K/Akt pathway causes
cell proliferation, dissemination, and survival of cancer cells [11]. PI3K/Akt signaling aggravated
transforming growth factor-β (TGF-β)-induced EMT in A549 lung cancer cells [12].
At present, there is no effective treatment for metastatic melanoma, and five-year survival does
not exceed 15% in patients with metastatic disease. Hence, researchers have focused on effective
compounds from natural sources to manage metastatic disease. In this regard, the role of many natural
products and phytochemicals in regulation of EMT in various cancer models through attenuation
of primary signaling pathways has been established [13]. The flavonoids are an important group
of plant secondary metabolites that include varied classes of polyphenolic compounds found in
fruits, vegetables, roots, stems, flowers, beans and beverages, including tea and wine. Flavonoids
are well known for their multi-targeted anticancer properties, which include induction of apoptosis
as well as inhibition of cell proliferation, angiogenesis, and metastasis [14]. Flavonoids, such as
quercetin and luteolin, have shown efficacy against EMT in A431 melanoma cells [15]. Cirsiliol
(5,3’,4’-trihydroxy-6,7-dimethoxyflavone) is a flavonoid belonging to the class flavone. It was first
isolated from the desert plant Achillea fragrantissima [16]. Later, it was also found in other sources,
such as chloroform extract of the aerial parts of Centaurea jacea L. [17], epicuticular wax of the
leaves of Arabidea brachipoda [18] and ethanolic extract of the aerial part of Artemisia scoparia [19].
Emerging studies with cirsiliol revealed several therapeutic properties, such as anti-infective (against
human immunodeficiency virus, hepatitis C virus and toxoplasmosis), anti-obesity and anti-fungal
activities [18–20]. Cirsiliol was found to exhibit cell growth-inhibitory activities against various cancer
cells, such as HeLa, MCF-7 and A431 cells [17]. Cirsiliol along with rhamnetin restrained EMT and
radio-resistance in non-small cell lung cancer cell lines, NCI-H1299 and NCI-H460, by inhibiting the
overexpression of Notch 1 [21]. Moreover, cirsiliol exhibited antiproliferative activity by inhibiting
arachidonate-5-lipooxygenase in human leukemic cell lines, such as K562, Molt-4B and HL-60 [22].
Nevertheless, therapeutic potential of cirsiliol against metastatic melanoma has not been studied yet as
per our knowledge. Accordingly, the present study was aimed to investigate the potential of cirsiliol
in modulating the aggressive behavior of metastatic melanoma cells, such as EMT, and associated
molecular mechanisms of action.
2. Results
2.1. Effects of Cirsiliol on Mortality, Colony Formation and Cell Cycle of Metastatic Melanoma Cells
MTT assay conducted for evaluating the effect of cirsiliol on the mortality of B16F10 metastatic
melanoma cells revealed that treatment with this phytochemical at a concentration of 10 µM for 24 h
or 48 h did not induce any mortality. The vehicle dimethyl sulfoxide (DMSO) (0.01%) did not have any
effect on the viability of B16F10 cells. Cirsiliol at 10 µM induced 28% mortality of B16F10 cells only
after 72 h (Figure 1A). A 50% inhibitory concentration(IC50) of cirsiliol could not be achieved at 24 h or
48 h. Even cirsiliol (50 µM) after 48 h caused 44% mortality in B16F10 cells after which a plateau was
achieved. In case of 72 h treatment, IC50 of cirsiliol was found to be 25 µM. Cirsiliol at 10 µM for 48 h
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was also nontoxic for HaCaT normal skin keratinocytes (data not shown). Hence, the non-cytotoxic
concentration of cirsiliol (10 µM) for 48 h treatment period was used for subsequent studies.
Colony formation assay exhibited significant inhibition of survival of fibronectin (FN)-induced
and cirsiliol (10 µM/48 h)-treated B16F10 cells compared to B16F10 cells exposed to FN only (Figure 1B).
No significant alteration of percentage of B16F10 cells in different phases of cell cycle was observed
between FN-induced and cirsiliol (10 µM/48 h)-treated cells and FN-induced B16F10 cells treated with
vehicle (Figure 1C).
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Figure 1. Effects of cirsiliol on cell mortality, colony formation and cell cycle of B16F10 cells. (A) 
Concentration- and time-dependent cytotoxic effect of cirsiliol. (B) Colony formation assay 
micrographs (400× magnification) and graphical representation of significant inhibition of surviving 
fraction in fibronectin (FN+) and cirsiliol (Cir) [10 µM/48 h]-treated cells compared to cells exposed 
to FN only. (C) No significant alteration of percentage of cells in different phases of cell cycle was 
observed between FN+/Cir (10 µM/48 h) cells and FN-induced cells treated with vehicle as depicted 
by representative figure and graph. All quantitative results are expressed as mean±standard 
deviation (SD) based on three replicates. M1: Sub G1; M2: G0-G1; M3: S; and M4: G2/M. 
2.2. Cirsiliol Inhibited Migratory Potential of FN-Induced Melanoma Cells  
Cell migration is the key to embryonic development, wound healing and cancer metastasis by 
inducing EMT which is highly conserved transitional program characterized by alterations at 
morphological, structural and molecular levels [23]. Thus, we assessed the effect of cirsiliol on the 
migratory potential of FN-induced B16F10 cells by wound healing assay. The results exhibited slow 
healing of the wound/scratch in the monolayer of B16F10 cells treated with cirsiliol (10 µM/48 h) in 
comparison to those treated only with FN (Figure 2A). By the end of 16 or 24 h, the wound closure 
was significantly inhibited by cirsiliol (10 µM/48 h) in FN-induced cells (Figure 2B). This was 
further validated by trans-well migration assay where cirsiliol (10 µM/48 h) inhibited the migration 
of FN-induced cells by 80% (Figures 2C,D). 
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2.2. Cirsiliol Inhibited Migratory Potential of FN-Induced Melanoma Cells
Cell migration is the key to embryonic development, wound healing and cancer metastasis
by inducing EMT which is highly conserved transitional program characterized by alterations at
morphological, structural and molecular levels [23]. Thus, we assessed the effect of cirsiliol on the
migratory potential of FN-induced B16F10 cells by wound healing assay. The results exhibited slow
healing of the wound/scratch in the monolayer of B16F10 cells treated with cirsiliol (10 µM/48 h)
in comparison to those treated only with FN (Figure 2A). By the end of 16 or 24 h, the wound
closure was significantly inhibited by cirsiliol (10 µM/48 h) in FN-induced cells (Figure 2B). This was
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further validated by trans-well migration assay where cirsiliol (10 µM/48 h) inhibited the migration of
FN-induced cells by 80% (Figure 2C,D).
 Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  4 of 19 
 
Figure 2. Effect of cirsiliol on migratory potential of B16F10 cells. (A) Wound healing assay showed 
reduction in the migratory property of FN+/Cir (10 µM/48 h)-treated B16F10 cells with respect to 
fibronectin (FN+) [20 µg/mL]-induced cells even after 24 h of monitoring. (B) The distance of wound 
closure (measured by image J software in pixels/cm) was much more in case of FN+/Cir (10 µM/48 h) 
treated B16F10 cells than FN+-induced cells. (C) Trans-well migration assay micrographs (400× 
magnification) showed compromised migratory property in FN+/Cir (10 µM/48 h)-treated B16F10 
cells compared to FN+ B16F10 cells. (D) The percentage of cells which migrated across the Boyden’s 
chamber were significantly less in case of FN+/Cir (10 µM/48 h)-treated cells than the FN+-induced 
cells. Cir: cirsiliol; FN+: cells were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 °C) petri 
dishes and further incubated for 48 h in presence of 5% fetal bovine serum (FBS) for induction of 
EMT; FN+/Cir (10 µM/48 h): cells were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 °C) 
petri dishes and subjected to a non-cytotoxic dose of cirsiliol (10 µM) treatment for 48 h. All 
quantitative results are expressed as mean±SD based on three replicates. 
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metalloproteinases play a vital role. Gelatinases are important for tissue degradation and cellular 
infiltration. MMP-2 plays a significant role in angiogenesis and tumor formation, while MMP-9 is 
vital for metastasis and tumor development. Both pro and active form of MMP-2 and MMP-9 were 
significantly reduced with cirsiliol (10 µM/48 h) in FN-induced cells as evident from the 
zymography results (Figures 3A,B). The transcript profile also exhibited suppression of MMP-9 
expression by cirsiliol (10 µM/48 h) in FN+-induced cells (Figures 3C,D). However, MMP-2 did not 
show any change of expression in the presence or absence of cirsiliol (Figures 3C,D). 
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induction of EMT; FN+/Cir (10 µM/48 h): cells were seeded in pre-coated (cellular FN 20 µg/mL for
2 h at 37 ◦C) petri dishes and subjected to a non-cytotoxic dose of cirsiliol (10 µM) treatment for 48 h.
All quantitative results are expressed as mean ± SD based on three replicates.
2.3. Cirsiliol Reduced Matrix Metalloprotienase-9 (MMP-9) Activity and Expression in FN-Induced Cells
Remodeling of cancer cells is important for migration, invasion and metastasis in which matrix
metalloproteinases play a vital role. Gelatinases are important for tissue degradation and cellular
infiltration. MMP-2 plays a significant role in angiogenesis and tumor formation, while MMP-9 is
vital for metastasis and tumor development. Both pro and active form of MMP-2 and MMP-9 were
significantly reduced with cirsiliol (10 µM/48 h) in FN-induced cells as evident from the zymography
results (Figure 3A,B). The transcript profile also exhibited suppression of MMP-9 expression by cirsiliol
(10 µM/48 h) in FN+-induced cells (Figure 3C,D). However, MMP-2 did not show any change of
expression in the presence or absence of cirsiliol (Figure 3C,D).
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cells were treated with FN+/Cir (10 µM/48 h). (B) Mean band intensities showed that FN+/Cir (10 
µM/48 h) significantly inhibited activity of both pro and active forms of MMP-2 and MMP-9 than 
FN+- treated B16F10 cells. (C) Inhibition of MMP-9 expression by FN+/Cir (10 µM/48 h) with respect 
to FN+-induced cells. On the other hand, transcript profile of MMP-2 did not show any significant 
change of expression by FN+/Cir (10 µM/48 h) with respect to FN+-induced cells. (D) FN+/Cir (10 
µM/48 h) caused significant inhibition of mean MMP-9 mRNA expression and no change of mean 
MMP-2 mRNA expression in comparison to only FN-induced cells. Cir: cirsiliol; FN+: cells were 
seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 °C) petri dishes and further incubated for 
48 h in presence of 5% FBS for induction of EMT; FN+/Cir (10 µM/48 h): cells were seeded in pre-
coated (cellular FN 20 µg/mL for 2 h at 37 °C) petri dishes and treated with subjected to a non-
cytotoxic dose of cirsiliol (10 µM) treatment for 48 h; M: DNA step ladder 100 bp. All quantitative 
results are expressed as mean±SD based on three replicates. 
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4C) and mean band intensity (Figure 4D). These findings were confirmed at the transcriptional level 
as shown with representative images (Figure 4E) and mean band intensities of mRNA (Figure 4F). 
However, vimentin expression did not show any significant change in either protein (Figures 4C,D) 
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2.4. Cirsiliol Altered Expression of Cadherins in FN-Induced B16F10 Cells
EMT alters the cell to cell adhesion receptors by downregulation of the E-cadherin and
upregulation of neural (N)-cadherin. With initiation of EMT, the cell to cell adhesion junctions are
lost and the proteins associated are either degraded or relocated [24]. Based on immunocytochemical
analysis, FN-induced melanoma cells elicited downregulation of E-cadherin and upregulation of
N-cadherin compared to control cells (Figure 4A,B). Following the treatment of the FN-induced cells
with cirsiliol (10 µM/48 h), the cellular expression of E-cadherin was upregulated by 4.3-fold and that of
N-cadherin was downregulated by 3.4-fold (Figure 4A,B). Western blot analysis reflected similar trend
of E-cadherin and N-cadherin expression in FN+/cirsiliol (10 µM/48 h) with respect to FN+ cells as
depicted in the representative image (Figure 4C) and mean band intensity (Figure 4D). These findings
were confirmed at the transcriptional level as shown with representative images (Figure 4E) and mean
band intensities of mRNA (Figure 4F). However, vimentin expression did not show any significant
change in either protein (Figure 4C,D) or mRNA level (Figure 4E,F) between FN+/cirsiloil (10 µM/48 h)
cells and FN+ melanoma cells.
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Figure 4. Effect of cirsiliol on epithelial and mesenchymal markers in B16F10 cells. (A) 
Representative micrographs of immunocytochemistry (400× magnification) and (B) graph with 
percentage of cells expressing E-cadherin and N-cadherin revealed that FN+/Cir (10 µM/48 h) 
increased cytoplasmic expression of E-cadherin and decreased that of N-cadherin with respect to 
FN+-induced cells. (C) Images of western blot and (D) quantitative expression of mean band 
intensity exhibited that FN-induced downregulation of E-cadherin and upregulation of N-cadherin 
was significantly reversed with FN+/Cir (10 µM/48 h). Vimentin did not show any significant change 
of expression by FN+/Cir (10 µM/48 h) with respect to FN+-induced cells. (E) The transcript profile 
images and the (F) mean band intensities showed that FN+-induced downregulation of E-cadherin 
and upregulation of N-cadherin was significantly counteracted with FN+/Cir (10 µM/48 h). Vimentin 
did not show any significant change of mRNA expression by FN+/Cir (10 µM/48 h) in comparison to 
FN+-induced cells. Cir: cirsiliol; FN+: cells were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 
37 °C) petri dishes and further incubated for 48 h in presence of 5% FBS for induction of EMT; 
FN+/Cir (10 µM/48 h): cells were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 °C) petri 
dishes and treated with subjected to a non-cytotoxic dose of cirsiliol (10 µM) treatment for 48 h; M: 
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mesenchymal phenotypes, including activation MMP expression [25]. Immunocytochemistry 
revealed that cirsiliol (10 µM/48 h) reduced nuclear localization of both Snail and Twist in the FN-
treated cells that had increased after EMT induction with FN (Figure 5A). The percentage of cells 
expressing nuclear Snail were decreased by 3.9-fold and that of Twist was decreased by 7.3-fold in 
case of cells treated with FN+/cirsiliol (10 µM/48 h) compared to FN+ melanoma cells (Figure 5B). 
The western blot results exhibited the similar effect of cirsiliol (10 µM/48 h) to reduce the expression 
of Snail and Twist in FN-induced cells (Figure 5C). However, cirsiliol did not exhibit any effect on 
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2.5. Cirsiliol Reduced FN-Induced EMT Transcription Factors in B16F10 Cells
The mesenchymal characteristics in a cell are induced by master regulatory transcription factors,
such as Snail, Slug and Twist. They control the expression of E-cadherin as well as other mesenchymal
phenotypes, including activation MMP expression [25]. Immunocytochemistry revealed that cirsiliol
(10 µM/48 h) reduced nuclear localization of both Snail and Twist in the FN-treated cells that had
increased after EMT induction with FN (Figure 5A). The percentage of cells expressing nuclear Snail
were decreased by 3.9-fold and that of Twist was decreased by 7.3-fold in case of cells treated with
FN+/cirsiliol (10 µM/48 h) compared to FN+ melanoma cells (Figure 5B). The western blot results
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exhibited the similar effect of cirsiliol (10 µM/48 h) to reduce the expression of Snail and Twist
in FN-induced cells (Figure 5C). However, cirsiliol did not exhibit any effect on Slug (Figure 5C).
The mean band intensities reflected similar modulation of Snail, Twist and Slug by FN+/cirsiliol
(10 µM/48 h) with respect to FN+ B16F10 cells (Figure 5D).
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Figure 5. Effect of cirsiliol on the EMT transcription factors of B16F10 cells. (A) Representative 
micrographs of immunocytochemistry (400× magnification) and (B) quantitative analysis of cells 
indicated reduced nuclear expression of Snail and Twist in FN+/Cir (10 µM/48 h)-treated cells 
compared to FN+-induced cells. (C) Representative images of western blot and (D) the normalized 
mean band intensity graphs indicated reduced expression of Snail and Twist in FN+/Cir (10 µM/48 
h) treated cells in comparison with FN+-induced cells. Cir: cirsiliol; FN+: cells were seeded in pre-
coated (cellular FN 20 µg/mL for 2 h at 37 °C) petri dishes and further incubated for 48 h in presence 
of 5% FBS for induction of EMT; FN+/Cir (10 µM/48 h): cells were seeded in pre-coated (cellular FN 
20 µg/mL for 2 h at 37 °C) petri dishes and treated with subjected to a non-cytotoxic dose of cirsiliol 
(10 µM) treatment for 48 h. All quantitative results are expressed as mean±SD based on three 
replicates. 
2.6. Cirsiliol Suppressed PI3K/Akt Signaling in FN-Induced B16F10 Cells 
The PI3K/Akt signaling plays an important role in regulating the mechanism of EMT by 
affecting a variety of cellular and physiological processes. On one hand, Akt regulates the 
functioning of Twist by phosphorylation that again acts in a positive feedback loop with Twist to 
enhance the pro-EMT function while on the other hand, it prevents degradation of Snail as well as 
enhancing its intracellular expression [26,27]. It has also been found to enhance the expression of 
MMP-9 that remodels tissue and aids in invasion. The current investigation of the expression of 
these regulatory molecules revealed a significant reduction in phosphorylation status of PI3K at 
tyrosine residue 508 and Akt at serine 473 by FN+/cirsiliol (10 µM/48 h) in comparison to FN-
induced B16F10 cells as evident from the western blot (Figure 6A) and the mean band intensities 
(Figure 6B). To further validate the mechanistic role of cirsiliol (10 µM/48 h) through PI3K, cells 
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PI3K/Akt pathway against FN-induced EMT in B16F10 cells. 
Figure 5. Effect of cirsiliol on the EMT transcription factors of B16F10 cells. (A) Representative
micrographs of immunocytochemistry (400× magnification) and (B) quantitative analysis of cells
indicated reduced nuclear expression of Snail and Twist in FN+/Cir (10 µM/48 h)-treated cells
compared to FN+-induced cells. (C) Representative images of western blot and (D) the normalized
ean band intensity graphs indicated reduced expression of Snail and Twist in FN+/Cir (10 µM/48 h)
treated cells in comparison with FN+-induced cells. Cir: cirsiliol; FN+: cells were seeded in pre-coated
(cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes and further incubated for 48 h in presence of 5% FBS
for induction of EMT; FN+/Cir (10 µM/48 h): cells were seeded in pre-coated (cellular FN 20 µg/mL
for 2 h at 37 ◦C) petri dishes an treated with subjected to a non-cytotoxic dose of cirsiliol (10 µM)
treatment for 48 h. All quantitative results are expressed as mean ± SD based on three replicates.
Scanned blots of Figure 5 are showed in Figure S2.
2.6. Cirsiliol Suppressed PI3K/Akt Signaling in FN-Induced B16F10 Cells
The PI3K/Akt signaling plays an important role in regulating the mechanism of EMT by affecting
a variety of cellular and physiological processes. On one hand, Akt regulates the functioning of Twist
by phosphorylation that again acts in a positive feedback loop with Twist to enhance the pro-EMT
function while on the other hand, it prevents degradation of Snail as well as enhancing its intracellular
expression [26,27]. It has also been found to enhance the expression of MMP-9 that remodels tissue and
aids in invasion. The current investigation of the expression of these regulatory molecules revealed a
significant reduction in phosphorylation status of PI3K at tyrosine residue 508 and Akt at serine 473 by
FN+/cirsiliol (10 µM/48 h) in comparison to FN-induced B16F10 cells as evident from the western
blot (Figure 6A) and the mean band intensities (Figure 6B). To further validate the mechanistic role
of cirsiliol (10 µM/48 h) through PI3K, cells were treated with PI3K inhibitor followed by induction
ith FN. Analysis of the E-cadherin expression by western blot revealed elevation in its expression
in the case of FN+ cells with respect to the control. The expression of E-cadherin was elevated with
FN+/cirsiliol (10 µM/48 h) in comparison to FN+ cells (Figure 6C). The mean band intensities of
E-cadherin also reflected a similar pattern of upregulation in the presence of PI3K inhibitor with FN+
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and further incubated for 48 h in the presence of 5% FBS for induction of EMT; FN+/Cir (10 µM/48 h):
cells were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes and treated with
subjected to a non-cytotoxic dose of cirsiliol (10 µM) treatment for 48 h. All quantitative results are
expressed as mean ± SD based on three replicates. Scanned blots of Figure 6 are showed in Figure S3.
2.7. Cirsiloil Suppressed Nuclear Factor-κB p65 (NF-κB p65) Signaling in FN-Induced B16F10 Cells
The PI3K/Akt pathway also plays a major role in activation of NF-κB p65 subunit that in
turn is associated with the induction of cellular expression of Snail [28]. Immunocytochemical
analysis revealed that cirsiliol (10 µM/48 h) treatment reduced the nuclear localization of NF-κB
p65 in FN-induced B16F10 cells in comparison with FN+ cells (Figure 7A). The percentage of cells
expressing nuclear NF-κB p65 decreased with FN+/cirsiliol (10 µM/48 h) compared to FN+ cells
(Figure 7B). The expression of nuclear NF-κB p65 was downregulated with FN+/cirsiliol (10 µM/48 h)
in comparison with FN+ cells as evident from western blot results (Figure 7C,D). Similar results were
observed with the transcriptional profile of NF-κB p65 (Figure 7E,F).
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of the normalized band intensities of nuclear NF-κB p65 in FN+/Cir (10 µM/48 h) treated cells in
comparison to FN+ B16F10 cells. (E) mRNA images and (F) mean band intensities of mRNA of
NF-κB p65 in FN+/Cir (10 µM/48 h)-treated cells in comparison to FN+ B16F10 cells. Cir: cirsiliol;
FN+: cells were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes and further
incubated for 48 h in presence of 5% FBS for induction of EMT; FN+/Cir (10 µM/48 h): cells were seeded
in pre-coated (cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes and subjected to a non-cytotoxic
dose of cirsiliol (10 µM) treatment for 48 h, M: DNA step ladder 100 bp. All quantitative results are
expressed as mean ± SD based on three replicates. Scanned blots of Figure 7 are showed in Figure S4.
3. Discussion
EMT is the switching of epithelial cells to mesenchymal-like cells by loss of apical-basal
polarity and cell-cell adhesion, switch of cell surface markers and enhanced migratory and invasive
capacities [23]. The molecular mechanism of EMT is associated with the downregulation of E-cadherin
and upregulation of mesenchymal markers, such as N-cadherin, fibronectin and vimentin [29].
E-cadherin transcription is inhibited by transcription factors, such as ZEB, Snail and Twist [30].
Phytochemicals have been found to possess numerous health-promoting and disease-preventive
activities. Since there is no effective treatment against metastatic melanoma, various phytochemicals
have been widely explored for their antitumor and antimetastatic potential. C. jacea L. (also known
as brown knapweed or brownray knapweed) is a perennial herb with widespread distribution in
Europe. T e flavone cirsiliol was isolated from the chloroform extract of C. jacea L. and it showed
antiproliferative activity agai st HeLa, MCF-7 nd A431 tumor c ll lines [17]. Cirsiliol exhibited
growth-inhibitory activity against MCF-7 breast cancer cells by inducing cytochrome P450 fami y 1
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enzyme [31]. Thus, antiproliferative efficacy of cirsiliol against tumor cell lines had been well explored,
but its antimetastatic potential has not been investigated before as per our knowledge.
Melanoma is characterized by EMT-mediated tumor progression [5]. Induction of EMT by
TGF-β is a well-established phenomenon. A non-cytotoxic concentration of cirsiliol (10 µM/48 h)
was effective in reducing the migratory properties of B16F10 cells, which prompted us to investigate
its role against EMT in melanoma cells. FN is one of the prime components of extracellular matrix
which is well-known for regulating normal cell adhesion and migration. Over-expression of FN,
reported in several solid carcinomas, has been propagated to be beneficial for establishment of an
ideal microenvironment for tumor growth [32]. In the present study, we tried to explore the induction
of EMT with extracellular matrix (ECM) component FN. Since “cadherin switch” characterized by
downregulation of E-cadherin and upregulation of N-cadherin is regarded as the hallmark of EMT,
we investigated the status of E-cadherin and N-cadherin following FN treatment. FN-stimulated
melanoma cells exhibited robust downregulation of E-cadherin and upregulation of N-cadherin.
Interestingly, the non-cytotoxic concentration of cirsiliol was found to reverse this cadherin switch.
Cirsiliol upregulated E-cadherin expression and downregulated N-cadherin expression in FN-induced
B16F10 melanoma cells. This was in congruence with previous studies where cirsiliol along with
rhamnetin downregulated Notch-1-mediated radio-resistance and EMT phenotypes in non-small cell
lung carcinoma cell lines [21].
The occurrence of EMT is associated with several complex signal transduction pathways,
including the PI3K/Akt signaling pathway [33]. The PI3K/Akt pathway, crucially involved in
metastatic melanoma [34], is responsible for cell proliferation, anabolism, dissemination, and tumor
survival [2]. The flavonoid fisetin impeded EMT in A375 melanoma cells by hindering the
PI3K/Akt/mammalian target of rapamycin (mTOR) pathway [35]. ECM component FN was reported
to be associated with PI3K/Akt-mediated metastasis and cancer cell resistance to apoptosis [36]. In the
present study, FN substantially elevated the expression of pPI3KTyr508 and pAKTSer473 in melanoma
cells which were suppressed by cirsiliol treatment. Moreover, it was observed that with the use of
PI3K inhibitor, E-cadherin expression increased which was further elevated in the presence of cirsiliol.
This clearly indicated that suppression of E-cadherin which is the hallmark of EMT progression,
might have been achieved through downregulation of PI3K/Akt pathway.
The EMT transcription factors, such as Snail and Slug, can shuttle between the cytoplasm
and the nucleus in order to bind E-box promoter of E-cadherin, inhibit its expression and activate
EMT [37]. The PI3K/Akt signaling pathway on one hand, prevents glycogen synthase kinase
3β (GSK3β)-mediated degradation of Snail and on the other hand, directly activates expression
of Snail [27]. In accordance with the above studies, FN-induced B16F10 cells exhibited that
phosphorylation of PI3K at Tyr508 and Akt at Ser473 caused upregulation of Snail and downregulation
of E-cadherin, and that cirsiliol was effective in counteracting these effects. The nuclear localization of
Snail influences the transcription of β-catenin and also increases the expression of vimentin, fibronectin,
MMP-2 and MMP-9 [38]. The present study showed reduced nuclear expression of Snail by cirsiliol
which was further supported by the retarded expression and activity of MMP-9 in FN-induced
melanoma cells.
Twist is a basic helix-loop-helix transcription factor with a strong ability to induce the EMT.
Twist can enhance the biological activity of Akt, mainly through interaction with the E-box element
in the Akt2 promoter. Akt2 is a crucial factor in the PI3K/Akt signaling pathway, as it regulates cell
proliferation, differentiation and survival in physiological and pathological processes [39]. Akt and
Twist are involved in a positive feedback loop, which subsequently promoted EMT [10]. Quercetin
prevented epidermal growth factor (EGF)-induced EMT via the epidermal growth factor receptor
/P13K/Akt/extracellular signal-regulated kinase 1/2 pathway and by suppressing transcription
factors, Snail, Slug and Twist, in PC-3 prostate cancer cells [40]. In conformity with the above studies,
it was observed that along with suppression of the PI3K/Akt pathway cirsiliol was capable of inhibiting
Twist expression in FN-induced B16F10 cells.
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NF-κB regulation may occur by a number of ways of which the inhibitor of κB (IκB)
negative-feedback loop forms a major pathway. In the present study, though the exact mechanism of
inhibition of NF-κB is not known, cirsiliol could possibly interfere with the NF-κB pathway upstream of
IκBα phosphorylation or activate the IκBα negative feedback loop which, in turn, caused nuclear export
and degradation of NF-κB. In congruence with this, other investigators have reported that activation of
NF-κB causes the degradation of the IκBs, which facilitates nuclear translocation of NF-κB complexes.
Subsequently, IκBα is newly synthesized which enters the nucleus, dissociates NF-κB from DNA,
and escorts it back to the cytoplasm [41]. Moreover, plant polyphenols have been reported as specific
blockers of NF-κB transcriptional activity by targeting events in the nucleus. Epigallocatechin-3-gallate
(EGCG), a tea polyphenol, was identified as a novel histone acetylase inhibitor. EGCG repressed the
recruitment of p300 with an increased binding of the histone deacetylase 3, blocking the acetylation
of p65 and NF-κB target gene expression in response to myriad stimuli [42]. Curcumin, an active
component of turmeric, was reported to inhibit the phosphorylation and degradation of IκBα and the
subsequent translocation of the p65 subunit of NF-κB to the nucleus [43]. NF-κB also participates in the
induction of EMT by PI3K/Akt. Ras activates the PI3K/Akt signaling pathway, which consequently
reactivates NF-κB to induce the expression of Snail, and this, in turn, leads to the downregulation of
E-cadherin expression [27]. Resveratrol, a phytochemical present in grapes, blueberries, raspberries,
mulberries, and peanuts, inhibited TGF-β-induced EMT in human pancreatic cancer cell lines, BxPC-3
and Panc-1, via suppression of PI3K/Akt/NF-κB signaling pathways [44]. The present study also
elicited that cirsiliol was effective in reducing the nuclear expression of NF-κB p65 subunit in
FN-stimulated B16F10 cells. This might have been due to reduced phosphorylation of the PI3K/Akt
pathway by cirsiliol.
Prior studies show that FN activates the PI3K/Akt pathway [36], and phosphorylated AktSer473
upregulates NF-κB [45], Snail [27] and Twist [46]. PI3K/Akt directly activates Snail as well as through
NF-κBp65-mediated pathway [27,47] and bidirectional mode of interaction exists between Akt and
Twist [10] as well as between Snail and Twist [48]. The transcription factors Snail and Twist are
responsible for downregulation of E-cadherin and progression of EMT [49]. In this study, we observed
that cirsiliol was effective in downregulating the expression of PI3KTyr508, AktSer473, Snail and Twist
which altogether might have been responsible for upregulation of E-cadherin, downregulation of
N-cadherin and inhibition of FN-induced EMT in B16F10 cells (Figure 8).
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Figure 8. Mechanism of suppression of FN-induced EMT by cirsiliol in B16F10 metastatic melanoma 
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suppressed E-cadherin. Cirsiliol was effective in inhibiting phosphorylation of the PI3K/Akt 
pathway, which in turn caused downregulation N-cadherin and upregulation of E-cadherin. The 
signaling pathways indicated within the red dotted line box are already established mechanisms. 
FN, fibronectin; ⊥, pathways inhibited by cirsiliol; → unidirectional mode of action; ↔, bidirectional 
mode of action. 
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4. Materials and Methods
4.1. Chemicals
Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine serum (FBS) were purchased
from Gibco Life Technologies Corporation (Grand Island, NY, USA). FN (440 KDa), protease inhibitor
cocktail tablets (complete, mini, and - ethylenediaminetetraacetic acid-free), were purchased from
Roche (Mannheim, Germany). Gelatin sepharose 4B beads were purchased from GE Healthcare
Bio-Sciences AB (Uppsala, Sweden). 3-(4,5-Dimethylthiazol-2-yl)-2-5-diphenyl-2H-tetrazolium
bromide (MTT) was purchased from Amresco (Solon, OH, USA). Primary antibodies (monoclonal
and polyclonal) to E-cadherin, vimentin, Twist, PI3K, PI3KTyr508, Akt, AktSer473, β-actin and PI3K
inhibitor were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Primary antibodies
to N-cadherin, Snail and Slug were purchased from Cell Signaling Technology (Beverly, MA, USA).
Secondary antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA, USA).
Super Signal West Femto Maximum sensitivity substrate for enhanced chemiluminescence was
purchased from Thermo Scientific (Rockford, IL, USA). RETROscript kit for reverse transcription
polymerase chain reaction (RT-PCR) was purchased from Ambion, Life Technologies (Grand Island,
NY, USA). TRIzol (for RNA isolation) was purchased from Thermo Fisher scientific (Waltham, MA,
USA) and GoTaq DNA polymerase for RT-PCR was procured from Promega (Madison, WI, USA).
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Primers for E-cadherin, N-cadherin, vimentin matrix MMP-9, MMP-2 and β actin were synthesized by
Integrated DNA Technologies, Inc. (Corallville, IA, USA). Costar trans-well plates were purchased
from Corning Inc. (Corning, NY, USA).
4.2. Extraction and Purification of Cirsiliol
Dried and ground aerial parts of C. jacea L. (Asteraceae) were extracted with methanol, and after
concentration, the extract was subjected to solvent-solvent partition with n-hexane and chloroform.
Chromatographic separation, including CC on silica gel and on polyamide, afforded the isolation of
cirsiliol (6,7-dimethoxy-5,3’,4’-trihydroxyflavone) in pure form as described previously [17].
4.3. Cell Culture
Highly metastatic B16F10 murine melanoma cell line was obtained from National Centre for Cell
Sciences (Pune, Maharashtra, India). Cells were cultured and maintained in DMEM-supplemented with
10% FBS, penicillin (100 U/mL) and streptomycin (100 µg/mL) at 37 ◦C in a humidified atmosphere of
5% CO2 incubator.
4.4. Cytotoxicity Assay
Cytotoxicity was determined by the MTT assay. Exponentially growing cells (1 × 104) were
seeded in 96-well plates. After 24 h of growth, the cells were treated with various concentrations of
cirsiliol. Doxorubicin was used as the positive control. Incubation was carried out at 37 ◦C for 24 h,
48 h and 72 h. A separate lane was also used as a vehicle control, i.e., DMSO; however, apart from
the cytotoxicity assays the DMSO concentration was not allowed to exceed 1% for other experiments.
MTT solution was added to each well (1.2 mg/mL) and incubated for 4 h. The reaction resulted in the
reduction of MTT by the mitochondrial dehydrogenases of viable cells to a purple formazan product.
The MTT-formazan product dissolved in DMSO was estimated by measuring absorbance at 570 nm in
a multi-wall microplate reader (Infinite M200, TECAN, Mannedrof, Switzerland).
4.5. Treatment of Cells
Cells were allowed to reach 70% confluency before treatment. Four sets of treatment were
followed for each experiment: (i) For control, cells (5 × 104) were seeded without any treatment;
(ii) Cells (5 × 104) were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes
and further incubated for 48 h in presence of 5% FBS for induction of EMT; (iii) Cells (5 × 104) were
seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes and treated with subjected
to a non-cytotoxic dose of cirsiliol (10 µM) treatment for 48 h (determined from cell viability assay);
and (iv) Cells (5 × 104) were seeded and subjected to cirsiliol (10 µM) treatment for 48 h (results not
shown since cirsiliol itself did not have any toxicity at this dose).
4.6. Colony Formation Assay
Cells were allowed to reach 70% confluency before treatment. Four sets of treatment were
followed for each experiment: (i) For control, cells (5 × 104) were seeded without any treatment;
(ii) Cells (5 × 104) were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes
and further incubated for 48 h in the presence of 5% FBS for induction of EMT; (iii) Cells (5 × 104)
were seeded in pre-coated (cellular FN 20 µg/mL for 2 h at 37 ◦C) petri dishes and treated with a
non-cytotoxic concentration of cirsiliol (10 µM) for 48 h (based on cell viability assay); and (iv) Cells
(5 × 104) were seeded and subjected to cirsiliol (10 µM) treatment for 48 h. Following each treatment,
50,000 cells were again seeded in plate. The cells were maintained in full media for 7 days, following
which they were fixed with ethanol, stained with crystal violet stain and observed under bright field
microscope (Olympus CX40, Tokyo, Japan) with 400×magnification.
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4.7. Cell Cycle Analysis
B16/F10 melanoma cells (2 × 104) were harvested, washed with PBS, and resuspended in sterile
PBS. Cells were fixed in ice-cold 100% methanol −20 ◦C for 1 h. The cells were centrifuged at 5000 rpm
for 10 min and the cell pellets were suspended in 1 mL of hypotonic buffer (0.5% Triton X-100 in PBS
and 0.5 mg/mL RNase), and incubated at 37 ◦C for 30 min. Subsequently, propidium iodide solution
(50 mg/mL) was added, and the mixture was allowed to stand for 1 h in darkness. The Fluorescence
emitted from the propidium iodide-DNA complex was quantitated after excitation of the fluorescent
dye by a flow cytometer (FACS Calibur, BD Biosciences, San Jose, CA, USA) using Cell Quest software
(BD Biosciences, San Jose, CA, USA) equipped with a 488 nm argon laser and a 525 ± 10 nm band pass
emission filter. Fluorescence was captured on a FL2H channel with linear amplification.
4.8. Wound Healing Assay
For cell motility determination, wound healing assay was performed following published
methods [50]. The monolayer was scratched with a sterile pipette tip in both treated and control
sterile petri-dishes followed by washing with serum free culture media (SFCM) for three times to
remove cellular debris. The cells were maintained in fresh SFCM and the wound closure was monitored
and photographed at 0, 8, 16, and 24 h using an inverted microscope and camera (Nikon, Tokyo, Japan).
To quantify the migrated cells, pictures of the initial wounded monolayers were compared with
the corresponding pictures of cells at the end of the incubation. Artificial lines fitting the cutting
edges were drawn on pictures of the original wounds and overlaid on the pictures of cultures after
incubation. Cells that had migrated across the black lines were counted in six random fields from each
triplicate treatment.
4.9. Transwell Migration Assay
Cell migration was assessed by using modified Boyden’s chamber system [51]. Briefly both treated
and control cells were added to Boyden’s invasion chamber (2 × 105 cells/chamber in triplicate) and
grown for 24 h in SFCM with the chamber inserted in DMEM containing 2% FBS as chemoattractant.
After 24 h, the media was aspirated from the inserts and the membrane was washed thrice with
phosphate-buffered saline (PBS). The cells were then fixed with methanol and stained with Gill’s
haematoxylin for 10 min. The cells which migrated towards the opposite side of the membrane
were viewed under inverted microscope. Cells from at least ten different fields were counted under
microscope (Olympus, Tokyo, Japan) equipped with Magnus Pro 3.7 software (Magnusoptics.com) at
40×magnification and the mean was calculated.
4.10. Gelatin Zymography
The activity of the gelatinases as detected by zymography are well established protocols for
observing the alterations of MMP-2/MMP-9, if any [52,53]. Gelatin zymography was performed to
evaluate the activities of matrix metalloproteinases (MMP-2 and MMP-9) in FN-induced cells both in
the presence and absence of cirsiliol according to a protocol described previously [54].
4.11. Extraction and Estimation of Cellular Proteins
Cell extraction of both treated and control B16F10 cells was performed with
radioimmunoprecipitation assay buffer buffer (Tris-HCl 50 mM, pH 7.5; NaCl 150 mM; NP40 10%;
sodium deoxycholate 0.5%; sodium dodecyl sulfate (SDS) 0.1%; protease inhibitor cocktail; NaF 0.01%;
Na3VO4 0.01%) at −80 ◦C for 1 h. Subsequently, it was followed with centrifugation at 12,000 rpm for
15 min. Cell supernatant was used for protein estimation. Protein estimation was done from the cell
lysate using the Lowry’s method [55].
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4.12. Western Blot Analysis
Equal amount of total protein (70 µg) of treated and control cells were suspended in
Laemmli’s buffer containing β-mercaptoethanol for 5 min at 90 ◦C. The samples were run on
sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (10%) and blotted onto
polyvinylidene difluoride membranes. The membranes were blocked using 5% bovine serum albumin
in Tris-buffered saline with Tween-20 (TBS-T); 50 mM Tris, 150 mM NaCl, and 0.05% Tween-20),
incubated with anti-E-cadherin, anti-N-cadherin, anti-vimentin, anti-Snail, anti-Slug, anti-Twist,
anti-Akt, anti-phosphoAktSer473 (p-Akt Ser473), anti-PI3K, anti-phosphoPI3KTyr 508 (p-PI3K Tyr
508) monoclonal and polyclonal antibodies [1:1000 (1 µg antibody in 1 mL buffer) dilution] overnight
at 4 ◦C, washed thrice in TBS-T, and incubated with horse peroxidase coupled secondary antibodies
for 90 min at 37 ◦C and washed thrice with TBST. Bands were visualized using the enhanced
chemiluminescence method.
4.13. Inhibitor Assay
B16F10 cells (3 × 105 cells/mL) were treated with PI3K inhibitor (LY 294002) (20 mM) for 1 h.
The cells were then seeded in plates previously coated with FN (20 µg/mL) as well as without FN.
Following this procedure of cell seeding, the cells were treated with cirsiliol (10 µm/48 h) and vehicle
control (0.01% DMSO/48 h). The cells were further processed for western blotting.
4.14. Immunocytochemistry
B16F10 cells were seeded on coverslips to 70% confluency and then treated with FN alone or
FN along with cirsiliol or left untreated for 24 h. After the treatment, the cells were washed with
cold PBS and fixed with ice cold methanol for 10 min at −20 ◦C. The non-specific binding sites were
blocked by blocking buffer for 1vh at 37 ◦C. The cells were then immunolabelled with anti-E-cadherin,
anti-N-cadherin, anti-Snail, anti-Twist and anti-NFκB p65 antibody overnight, washed with cold PBS
and incubated for 1 h with respective secondary antibodies for 1 h at room temperature. The cells were
again washed with PBS followed by 3,3’-diaminobenzidine treatment for 1 h at room temperature and
the nucleus were counterstained with hematoxylin for 10 min. The gradation of alcohol was carried
out and the coverslips were mounted on glass slides using distyrene, plasticizer and xylene (DPX)
and viewed under a microscope (Olympus, Tokyo, Japan) equipped with Magnus Pro 3.7 software at
40×magnification and the mean was calculated.
4.15. Semi-Quantitative RT-PCR
Total RNA from FN-induced B16F10 cells treated with or without cirsiliol was isolated using TRIzol
reagent and the isolated RNA was quantified spectrophotometrically. cDNA was synthesized from 2 µg
of total RNA using RETROscript kit. The cDNAs were amplified with specific primers for E-cadherin
(forward-CATGCAGTTCTGCCAGAGGA, reverse-ATCAGAATCAGCAGGGCGAG; NM_009864.3),
N-cadherin (forward-TGTGGAGGCTTCT GGTGAAA, reverse-CTTGAAATCTGCTGGCTCGC;
NM_007664.5), vimentin (forward-AACGAGTACCGGAGACAGGT; reverse-AGGTCATC
GTGATGCTGAGAA; NM_011701.4, MMP-9 (forward-TGAATCAGCTGGCTTTTGTG, reverse-
GTGGATAGCTCGGTGGTGTT; NM_013599.4), MMP-2 (forward-AGAGACTGGCTTAGGGC;
reverse-GTTGAAGGAAACGAGCGAAG; NM_008610.3), NF-kB (forward-CCAAACAGCGAGG
CTTCAGA; reverse-ATAGGTCTTCCGGCCCTTCT; NM_001177370.1) and β-actin (forward-
GTCCACCTTCCAGCAGATGTG, reverse-GCATTTGCGGTGGACGAT; NM_007393.5). The PCR
conditions included an initial denaturation step for 7 min at 95 ◦C and 35 cycles of 40 s at 95 ◦C, annealing
at 53.9 ◦C for E-cadherin, 53 ◦C for N-cadherin and 49.7 ◦C for MMP-9, 52 ◦C for β-actin and extension at
72 ◦C for 30 s. After the last cycle, a final extension was performed at 72 ◦C for 7 min. β-actin was used as
an internal control.
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4.16. Quantification of the Results
Bands of zymography, western blots and RT-PCR were quantitated using Image J Launcher
(version 1.4.3.67, https://imagej.net/Launcher).
4.17. Statistical Analysis
Quantitative results are expressed as mean ± SD. The statistical significance between treated
and control groups were determined using the one-way analysis of variance (ANOVA) followed by
the Dunnett t-test, where P value was set at 0.05 to check the statistical difference between groups.
The Dunnett t-test treats one group as a control and compares all other groups against it. All results
were computed and analyzed using the SPSS statistical software package 10.0 (SPSS, Chicago, IL, USA).
5. Conclusions
In conclusion, it may be determined that FN-activated PI3K/Akt phosphorylation which, in turn,
might have upregulated Twist and Snail via NF-κB p65. Snail might have further stabilized Twist
and suppressed E-cadherin. Cirsiliol was effective in suppressing PI3K/Akt/NF-κB pathway which,
in turn, caused downregulation of N-cadherin, Snail and Twist and upregulation of E-cadherin (Figure 8).
The inhibition of EMT signaling pathway was also reflected in the reduced migratory potential of the
FN-stimulated B16F10 cells. Therefore, cirsiliol may be regarded as a promising compound to suppress
EMT in the therapeutic management of metastatic melanoma. Nevertheless, further studies, including
in vivo experiments, are warranted to understand the full potential of our present findings.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/3/
608/s1.
Author Contributions: A.V. isolated the phytochemical cirsiliol under the supervision of J.H. P.P. performed the
experiments under the guidance of D.S. D.S. designed the study. P.P. and D.S. drafted the manuscript. A.B. critically
reviewed and edited the manuscript. All authors read and approved the final version of the manuscript.
Funding: This research received no external funding.
Acknowledgments: The authors would like to acknowledge the Director of Chittaranjan National Cancer
Institute (Kolkata, India) for providing the infrastructural facilities and Nivedita Sarkar for technical help
during experiments.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer Statistics 2018. CA Cancer J. Clin. 2018, 68, 7–30. [CrossRef]
[PubMed]
2. Paluncic, J.; Kovacevic, Z.; Jansson, P.J.; Kalinowski, D.; Merlot, A.M.; Huang, M.L.; Sahni, S.; Lane, D.J.;
Richardson, D.R. Roads to melanoma: Key pathways and emerging players in melanoma progression and
oncogenic signalling. Biochem. Biophys. Acta 2016, 1863, 770–784. [CrossRef] [PubMed]
3. Abildgaard, C.; Guldberg, P. Molecular drivers of cellular metabolic reprogramming in melanoma. Trends Mol.
Med. 2015, 21, 164–171. [CrossRef] [PubMed]
4. Singh, B.P.; Salama, A.K. Updates in Therapy for Advanced Melanoma. Cancers 2016, 8, 17. [CrossRef]
[PubMed]
5. Alonso, S.R.; Tracey, L.; Ortiz, P.; Perez-Gomez, B.; Palacios, J.; Pollan, M.; Linares, J.;
Serrano, S.; Saez-Castillo, A.I.; Sanchez, L.; et al. A high-throughput study in melanoma identifies
epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007, 67, 3450–3460.
[CrossRef]
6. Lamouille, S.; Xu, J.; Derynck, R. Molecular mechanisms of epithelial–mesenchymal transition. Nat. Rev.
Mol. Cell Biol. 2014, 15, 178–196. [CrossRef]
7. Ye, X.; Weinberg, R.A. Epithelial–mesenchymal plasticity: A central regulator of cancer progression.
Trends Cell Biol. 2015, 25, 675–686. [CrossRef]
Int. J. Mol. Sci. 2019, 20, 608 17 of 19
8. Caramel, J.; Papadogeorgakis, E.; Hill, L.; Browne, G.J.; Richard, G.; Wierinckx, A.; Saldanha, G.; Osborne, J.;
Hutchinson, P.; Tse, G.; et al. A switch in the expression of embryonic EMT-inducers drives the development
of malignant melanoma. Cancer Cell 2013, 24, 466–480. [CrossRef]
9. Denecker, G.; Vandamme, N.; Akay, O.; Koludrovic, D.; Taminau, J.; Lemeire, K.; Gheldof, A.; De Craene, B.;
Van Gele, M.; Brochez, L.; et al. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls
melanogenesis and melanoma progression. Cell Death Differ. 2014, 21, 1250–1261. [CrossRef]
10. Xu, W.; Yang, Z.; Lu, N. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal
transition. Cell Adhes Migr. 2015, 9, 317–324. [CrossRef]
11. De Luca, A.; Maiello, M.R.; D’Alessio, A.; Pergameno, M.; Normanno, N. The RAS/RAF/MEK/ERK and the
PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches.
Expert Opin. Ther. Targets 2012, 16 (Suppl. 2), S17–S27. [CrossRef]
12. Tan, W.J.; Tan, Q.Y.; Wang, T.; Lian, M.; Zhang, L.; Cheng, Z.S. Calpain 1 regulates TGF-β1-induced epithelial
mesenchymal transition in human lung epithelial cells via PI3K/AKT signalling pathway. Am. J. Transl. Res.
2017, 9, 1402–1409.
13. Das, B.; Sarkar, N.; Bishayee, A.; Sinha, D. Dietary phytochemicals in the regulation of epithelial
to mesenchymal transition and associated enzymes: A promising anticancer therapeutic approach.
Semin. Cancer Biol. 2018. [CrossRef] [PubMed]
14. Liao, C.Y.; Lee, C.C.; Tsai, C.C.; Hsueh, C.W.; Wang, C.C.; Chen, I.H.; Tsai, M.K.; Liu, M.Y.; Hsieh, A.T.;
Su, K.J.; et al. Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma.
Biomed. Res. Int. 2015, 2015, 840542. [CrossRef] [PubMed]
15. Lin, Y.S.; Tsai, P.H.; Kandaswami, C.C.; Cheng, C.H.; Ke, F.C.; Lee, P.P.; Hwang, J.J.; Lee, M.T. Effects of
dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431
epidermal cancer cells. Cancer Sci. 2011, 102, 1829–1839. [CrossRef] [PubMed]
16. Mustafa, E.H.; Abu Zagra, M.; Abdalla, S. Effect of Cirsiliol, a flavones isolated from Achillea fragrantissima,
on rat isolated ileum. Gen. Pharmacol. 1992, 23, 555–560. [CrossRef]
17. Forgo, P.; Zupko, I.; Molnar, J.; Vasas, A.; Dombi, G.; Hohmann, J. Bioactivity guided isolation of
anti-proliferative compounds from Centaurea jacea L. Fitoterapia 2012, 83, 921–925. [CrossRef]
18. Alcerito, T.; Barbo, F.E.; Negri, G.; Santos, D.Y.A.C.; Meda, C.I.; Young, M.C.M.; Chavez, D.; Blatt, C.T.T.
Foliar epicuticular wax of Arrabidea brachypoda: Flavonoids and anti-fungal activity. Biochem. Syst. Ecol. 2002,
30, 677–683. [CrossRef]
19. Yahagi, T.; Yakura, N.; Matsuzaki, K.; Kitanaka, S. Inhibitory effect of chemical constituents from Artemisia
scoparia Waldst. Et Kit. On triglyceride accumulation in 3T3-L1 cells and nitric oxide production in RAW
264.7 cells. J. Nat. Med. 2014, 68, 414–420. [CrossRef]
20. Prendergast, P.T. Use of Cirsiliol and Derivatives to Treat Infections. U.S. Patent 6,555,523 B1, 29 April 2003.
21. Kang, J.; Kim, E.; Kim, W.; Seong, K.M.; Youn, H.; Kim, J.W.; Kim, J.; Youn, B. Rhamnetin and Cirsiliol
induce radiosensitization and inhibition of epithelial- mesenchymal transition (EMT) by miR- 34a- mediated
suppression of Notch-1 expression in non- small cell lung cancer cell lines. J. Biol. Chem. 2013, 288,
27343–27353. [CrossRef]
22. Tsukada, T.; Nakashima, K.; Shirakawa, S. Arachidonate 5-lipoxygenase inhibitors show potent
antiproliferative effects on human leukemia cell lines. Biochem. Biophys. Res. Commun. 1986, 140, 832–836.
[CrossRef]
23. Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119,
1420–1428. [CrossRef] [PubMed]
24. Huang, R.Y.; Guilford, P.; Thiery, J.P. Early events in cell adhesion and polarity during epithelial-mesenchymal
transition. J. Cell Sci. 2012, 125, 4417–4422. [CrossRef] [PubMed]
25. Xi, Q.; Wang, Z.; Zaromytidou, A.I.; Zhang, X.H.; Chow-Tsang, L.F.; Liu, J.X.; Kim, H.; Barlas, A.;
Manova-Todorova, K.; Kaartinen, V.; et al. A poised chromatin platform for TGF-β access to master
regulators. Cell 2011, 147, 1511–1524. [CrossRef] [PubMed]
26. Xue, G.; Restuccia, D.F.; Lan, Q.; Hynx, D.; Dirnhofer, S.; Hess, D.; Rüegg, C.; Hemmings, B.A.
Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between
PI3K/Akt and TGF-β signaling axes. Cancer Discov. 2012, 2, 248–259. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2019, 20, 608 18 of 19
27. Lee, Y.J.; Han, H.J. Troglitazone ameliorates high glucose induced EMT and dysfunction of SGLTs through
PI3K/Akt, GSK-3beta, Snail1, and beta-catenin in renal proximal tubule cells. Am. J. Physiol. Ren. Physiol.
2010, 298, F1263–F1275. [CrossRef] [PubMed]
28. Julien, S.; Puig, I.; Caretti, E.; Bonaventure, J.; Nelles, L.; van Roy, F.; Dargemont, C.; de Herreros, A.G.;
Bellacosa, A.; Larue, L. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium
mesenchyme transition. Oncogene 2007, 26, 7445–7456. [CrossRef]
29. Schmalhofer, O.; Brabletz, S.; Brabletz, T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of
cancer. Cancer Metastasis Rev. 2009, 28, 151–166. [CrossRef]
30. Thiery, J.P.; Acloque, H.; Huang, R.Y.; Nieto, M.A. Epithelial-mesenchymal transitions in development and
disease. Cell 2009, 139, 871–890. [CrossRef]
31. Androutsopoulos, V.P.; Li, N.; Arroo, R.R. The methoxylated flavones eupatorin and cirsiliol induce CYP1
enzyme expression in MCF7 cells. J. Nat. Prod. 2009, 72, 1390–1394. [CrossRef]
32. Park, J. and Schwarzbauer, J.E.; Mammary epithelial cell interactions with fibronectin stimulate
epithelial-mesenchymal transition. Oncogene 2014, 33, 1649–1657. [CrossRef] [PubMed]
33. Chang, L.; Graham, P.H.; Hao, J.; Bucci, J.; Cozzi, P.J.; Kearsley, J.H.; Li, Y. Emerging roles of radioresistance
in prostate cancer metastasis and radiation therapy. Cancer Metastasis Rev. 2014, 33, 469–496. [CrossRef]
[PubMed]
34. Davies, M.A. The role of the PI3K-AKT pathway in melanoma. Cancer J. 2012, 18, 142–147. [CrossRef]
[PubMed]
35. Pal, H.C.; Diamond, A.C.; Strickland, L.R.; Kappes, J.C.; Katiyar, S.K.; Elmets, C.A.; Athar, M.; Afaq, F. Fisetin,
a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.
Oncotarget 2016, 7, 1227–1241. [CrossRef] [PubMed]
36. Cho, C.; Horzempa, C.; Jones, D.; McKeown-Longo, P.J. The fibronectin -II domain activates a PI3-Kinase/Akt
signalling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.
BMC Cancer 2016, 16, 574. [CrossRef] [PubMed]
37. Prokop, J.W.; Liu, Y.; Milsted, A.; Peng, H.; Rauscher, F.J., 3rd. A method for in silico identification of SNAIL/
SLUG DNA binding potentials to the E-box sequence using molecular dynamics and evolutionary conserved
amino acids. J. Mol. Model. 2013, 19, 3463–3469. [CrossRef] [PubMed]
38. Qiao, B.; Johnson, N.; Gao, J. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered
by transforming growth factor-b1 is Snail family-dependent and correlates with matrix metalloproteinase-2
and -9 expressions. Int. J. Oncol. 2010, 37, 663–668. [PubMed]
39. Agarwal, E.; Brattain, M.G.; Chowdhury, S. Cell survival and metastasis regulation by Akt signalling in
colorectal cancer. Cell Signal. 2013, 25, 1711–1719. [CrossRef]
40. Bhat, F.A.; Sharmila, G.; Balakrishnan, S.; Arunkumar, R.; Elumalai, P.; Suganya, S.; Singh, P.R.; Srinivasan, N.;
Arunakaran, J. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in
prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J. Nutr. Biochem. 2014, 25, 1132–1139.
[CrossRef]
41. Wan, F.; Lenardo, M.J. The nuclear signaling of NF-kappaB: Current knowledge, new insights, and future
perspectives. Cell Res. 2010, 20, 24–33. [CrossRef]
42. Choi, K.C.; Jung, M.G.; Lee, Y.H.; Yoon, J.C.; Kwon, S.H.; Kang, H.B.; Kim, M.J.; Cha, J.H.; Kim, Y.J.;
Jun, W.J.; et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B
lymphocyte transformation via suppression of RelA acetylation. Cancer Res. 2009, 69, 583–592. [CrossRef]
43. Li, W.; Ma, J.; Ma, Q.; Li, B.; Han, L.; Liu, J.; Xu, Q.; Duan, W.; Yu, S.; Wang, F.; et al. Resveratrol inhibits
the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI3K/Akt/NF-κB
pathway. Curr. Med. Chem. 2013, 20, 4185–4194. [CrossRef] [PubMed]
44. Singh, S.; Aggarwal, B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin
(diferuloylmethane) [corrected]. J. Biol. Chem. 1995, 270, 24995–25000. [CrossRef] [PubMed]
45. Barbera, M.J.; Puig, I.; Dominguez, D.; Julien-Grille, S.; Guaita-Esteruelas, S.; Peiro, S.; Baulida, J.; Franci, C.;
Dedhar, S.; Larue, L.; et al. Regulation of Snail transcription during epithelial to mesenchymal transition of
tumor cells. Oncogene 2004, 23, 7345–7354. [CrossRef] [PubMed]
46. Zhang, Y.Q.; Wei, X.L.; Liang, Y.K.; Chen, W.L.; Zhang, F.; Bai, J.W.; Qiu, S.Q.; Du, C.W.; Huang, W.H.; et al.
Over-Expressed Twist associates with markers of epithelial mesenchymal transition and predicts poor
prognosis in breast cancers via ERK and Akt activation. PLoS ONE 2015, 108, e0135851. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2019, 20, 608 19 of 19
47. De Craene, B.; van Roy, F.; Berx, G. Unraveling signalling cascades for the Snail family of transcription
factors. Cell Signal. 2005, 17, 535–547. [CrossRef] [PubMed]
48. Lindsey, S.; Langhans, S.A. Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal
transition. Front. Oncol. 2014, 4, 358. [CrossRef]
49. Wang, Y.; Shi, J.; Chai, K.; Ying, X.; Zhou, B.P. The Role of Snail in EMT and Tumorigenesis. Curr. Cancer
Drug Targets 2013, 13, 963–972. [CrossRef]
50. Sen, T.; Dutta, A.; Maity, G.; Chatterjee, A. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in
human laryngeal carcinoma cells by involving multiple signalling pathways. Biochimie 2010, 92, 1422–1434.
[CrossRef]
51. Falasca, M.; Raimondi, C.; Maffucci, T. Boyden chamber. Methods Mol. Biol. 2011, 769, 87–95. [CrossRef]
52. Ren, Z.; Chen, J.; Khalil, R.A. Zymography as a Research Tool in the Study of Matrix Metalloproteinase
Inhibitors. Methods Mol. Biol. 2017, 1626, 79–102. [PubMed]
53. Hu, X.; Beeton, C. Detection of functional matrix metalloproteinases by zymography. J. Vis. Exp. 2010, 45,
2445. [CrossRef] [PubMed]
54. Sinha, D.; Dutta, K.; Ganguly, K.K.; Biswas, J.; Bishayee, A. A novel synthetic oleanane triterpenoid
suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase
signalling axis. Mol. Carcinog. 2015, 54, 654–667. [CrossRef] [PubMed]
55. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with Folin phenol reagent.
J. Biol. Chem. 1951, 193, 265–275. [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
